Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension
September 29, 2016 11:45 ET
|
Quantum Genomics
Results enable initiation of additional hypertension studies for lead candidateCompany to conduct a U.S. Phase II trial in targeted patient population based on FDA advice PARIS and NEW YORK, Sept. ...
Quantum Genomics Announces Conference Call to Review Top-line Results from Phase IIa Study of QGC001 in Hypertension
September 22, 2016 12:00 ET
|
Quantum Genomics
PARIS and NEW YORK, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet...
Quantum Genomics to announce Phase IIa clinical trial results for high blood pressure on September 29, 2016
September 12, 2016 12:00 ET
|
Quantum Genomics
PARIS and NEW YORK, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet...
Quantum Genomics to Present at Rodman & Renshaw 18th Annual Conference in New York on September 13
September 06, 2016 08:00 ET
|
Quantum Genomics
CEO Lionel Ségard to discuss clinical updates and latest company developments PARIS and NEW YORK, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a...
Quantum Genomics granted two new U.S. patents covering lead product QGC001
May 17, 2016 12:00 ET
|
Quantum Genomics
PARIS & NEW YORK, May 17, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company developing new therapies for unmet medical needs in the...
Quantum Genomics Raises €8.6 Million in U.S. and Europe
March 24, 2016 08:00 ET
|
Quantum Genomics
PARIS and NEW YORK, March 24, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company focused on the development of new therapies for unmet...
Quantum Genomics Expands U.S. Presence to Advance Its Development Programs for Cardiovascular Diseases
February 03, 2016 14:20 ET
|
Quantum Genomics
Establishes U.S. Clinical Advisory BoardAnnounces Plans to Open U.S. Office PARIS, France, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a...